Arbovirus Testing Market Size, Growth Analysis Trend, 2026-2034
REPORT DETAILS
Arbovirus Testing Market Summary
The arbovirus testing market size was valued at USD 1.31 billion in 2025. The market is projected to grow at a CAGR of 4.7% from 2026 to 2034. Climate change and globalization are increasing vector-borne disease risks, fueling demand for arbovirus diagnostics.
Market Statistics
Key Takeaways
- North America led with a 39.4% revenue share in 2025. The rising burden of neglected tropical diseases (NTDs) and the growing incidence of West Nile virus drive the regional market dominance.
- Asia Pacific is anticipated to register the highest 5.4% CAGR. The growing patient population suffering from various arboviral diseases contributes to the regional market growth.
- The ELISA-based tests segment generated the largest revenue share of 44.8% in 2025. This is due to technological advancements in ELISA testing.
- The dengue segment held a considerable market share of 51.3% in 2025. The presence of a large patient pool suffering from dengue globally contributes to market demand in this segment.
- The public health laboratories segment dominated with a 46.2% share in 2025. This is owing to strong government funding and active outbreak surveillance..
Note: Figures and projections outlined in this report are the result of Polaris Market Research’s proprietary analytical processes, grounded in the latest available datasets and market observations.
Industry Dynamics
- The rising occurrence and resurgence of arthropod-borne viral infections have led to increased demand for arbovirus testing.
- Growing government initiatives for funding and awareness for research on arboviral testing is another factor shaping the market landscape.
- The shift towards rapid and extraction-free workflows is expected to create several market opportunities.
- Cross-reactivity in serological tests may present market challenges.
AI Impact on Arbovirus Testing Market
- The application of AI technology helps enhance the diagnosis of diseases related to arboviruses, especially dengue, Zika virus, and Chikungunya, by analyzing diagnostic data faster and more accurately.
- The AI tool can help accelerate diagnosis by recognizing patterns within test results in laboratories and helping clinicians interpret the complicated information.
- AI contributes to improved disease surveillance through the ability to monitor trends related to outbreaks, predict transmission risks, and geographic distribution.
- The application of AI is useful for improving the efficiency of test processes in laboratories and health agencies.
Key factors responsible for the market growth include rise in arthropod-borne viral diseases, coupled with awareness among individuals regarding regular check-up. Moreover, climate change, urbanization, and increased movement of people and goods also responsible for the spread of arboviral diseases. Furthermore, the recent advancements in the field of clinical diagnostics coupled with the increasing number of government initiatives with the objective of managing the burden of arboviral diseases are expected to propel the market growth during the forecast timeframe.
For instance, in March 2022, the World Health Organization announced the launch of the Global Arbovirus Initiative. This initiative is intended to tackle emerging arboviruses with epidemic & pandemic potential.
Source: Polaris Market Research Analysis
To Understand More About this Research: Download Sample Report
An increase in the investments towards research & development of new diagnostic products and growing awareness programs by various organizations will significantly propel the demand for arbovirus testing. Benefits of early testing of the patients suffering from various arboviral diseases coupled with increasing incidences of dengue, yellow fever, and chikungunya are anticipated to contribute to the arbovirus testing market expansion.
The development of newer molecular methods to perform various assays at a constant temperature by negating the need of expensive thermal cycling equipment is expected to prove beneficial for the market growth. For instance, in most cases, the time required for isothermal amplification has now reduced to 5 to 20 minutes.
Growth Factors
Increasing occurrence and resurgence of arthropod-borne viral infections will boost the arbovirus testing market growth
Arboviruses, also known as arthropod-borne viruses, are spread to humans and other vertebrates primarily through the species such as flies, mosquitoes, and ticks. The people living in the tropical and subtropical areas of the world are at a greater risk of developing arboviral diseases owing to the warm temperatures and humidity. Factors such as increasing incidence of arthropod-borne infections coupled with the high mortality associated these diseases will significantly contribute to the market growth.
For instance, according to the statistics published by the European Centre for Disease Prevention and Control, in 2023, around 6 million dengue cases were reported in 92 countries/territories across the world.
Government initiatives for awareness and fundings for research of arboviral testing drives the market growth
The potential of arboviral infections to cause outbreaks, severe illness, and public health emergencies has led many governments to consider them as critical health concerns. As a result, the governments are prioritizing these medical conditions and focusing on providing funds, allocating resources, and establishing programs that concentrate on control and prevention.
For instance, till 2023, 805 Sentinel Surveillance Hospitals with laboratory support have been built by the Government of India to improve dengue diagnostic capabilities in endemic states.
Moreover, governments across many countries are focused towards the partnerships with academic institutions and public health organizations to finance research and development activities for arbovirus infection. Such initiatives aimed at enhancing the current treatment options and diagnostic capabilities will prove beneficial for the growth of arbovirus testing market.
Restraining Factors
Restricted access to diagnostic testing methods and lack of awareness will hamper the overall arbovirus testing market
A large group of people in the developing countries are not aware about the availability of facilities required for the testing of arthropod-borne viruses. Moreover, restricted access to the advanced diagnostic techniques will result in the lower demand for arbovirus tests. Furthermore, the inadequate healthcare infrastructure in several under-developed countries is expected to limit the market growth in the coming years.
Source: Polaris Market Research Analysis
Report Segmentation
The market is primarily segmented based on test type, arboviral disease, end-use, and region.
| By Test Type | By Arboviral Disease | By End-use | By Region |
|
|
|
|
Source: Polaris Market Research Analysis
By Test Type Insights
The ELISA-based tests segment generated the largest revenue share of 44.8% in 2025
Based on test type, the ELISA-based tests held the largest share of arbovirus testing market. Technological advancements in ELISA testing for detection of arbovirus disorders and an increased focus on research and development of new ELISA tests are the factors responsible for such high share. Moreover, the ability to assess the efficacy of vector control measures and identification of high-risk areas are some of the factors that will boost the segment’s growth.
By Arboviral Disease Insights
The dengue segment accounted for the significant share of 51.3% in 2025
The dengue segment held the considerable market share in 2025. Presence of large patient pool suffering from dengue worldwide and growing mortalities with dengue are the primary factors favoring growth. In response to the growing burden of this disease, the companies are concentrating on the development and launch of testing products, which eventually fuels segmental expansion.
For instance, according to the statistics published by the European Centre for Disease Prevention and Control, in 2023, around 6,000 dengue related deaths were reported in 92 countries/territories across the world.
Source: Polaris Market Research Analysis
Supply Chain and Raw Material Availability
The effectiveness and efficiency of arbovirus testing systems depend directly on access to high-quality raw materials, including diagnostic reagents, antibodies, primers, enzymes, and specific consumables used in ELISA and RT-PCR tests. Having a reliable supply chain is crucial for providing ongoing surveillance of and responses to outbreaks of arboviral diseases, especially during their peak transmission periods. Disruptions in the supply chain, the use of specialist suppliers, and the fluctuation in the availability of reagents can affect laboratories' capacity for performing diagnostic tests. As such, manufacturers are working towards improving the regional supply chains, building up in-house reagent production capacities, and optimizing their supply chain operations.Continuous raw material access is crucial to enable rapid and accurate diagnoses of mosquito-transmitted viral infections around the world.
Regional Insights
North America region generated the largest revenue share of 39.4% in 2025
North America arbovirus testing market was the largest in 2025. Factors such as rising burden of Neglected Tropical Diseases (NTDs) and growing incidence of West Nile Virus & other forms of arboviral diseases contribute to the region’s share. Moreover, factors such as the changing distribution of the vectors mainly Aedes aegypti & Aedes albopictus coupled with the climate change leading to high temperature and humidity will fuel the market growth in the upcoming years.
For instance, according to the statistics published by the Centers for Disease Control & Prevention (CDC), in 2023, the number of cases of West Nile virus disease in the U.S. was 2,406.
Asia Pacific is anticipated to register the highest CAGR of 5.4% during the projected period. The growing patient population pool suffering from various arboviral diseases such as dengue, yellow fever, and chikungunya will contribute to the region’s growth. Moreover, rising focus of government initiatives to promote benefits of early detection coupled with the increased focus of companies to focus on untapped markets in this region will fuel the arbovirus testing market growth.
For instance, according to the data by the National Center for Vector Borne Diseases Control, in 2023, the number of suspected chikungunya cases in India was 93,455.
Source: Polaris Market Research Analysis
Key Market Players & Competitive Insights
Development of new tests by the companies is expected to strengthen their market position
The arbovirus testing market is moderately competitive. The other small and medium-sized companies are expected to improve their market shares owing to the increasing investments in research & developments for rapid tests, high efficacy with fewer side effects, and new product launches. For instance, in November 2021, Achiko AG announced the initiation of development of a DNA aptamer-based dengue fever diagnostic test.
Some of the major players operating in the global market include:
- Abbott (U.S.)
- Agilent Technologies, Inc., (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Copley Scientific (UK)
- DiaSorin SpA (Italy)
- Euroimmun AG (Germany)
- F. Hoffmann-La Roche Ltd (Switzerland)
- NovaTec Immundiagnostica GmbH (Germany)
- QIAGEN N.V. (Netherlands)
- Thermo Fisher Scientific, Inc. (U.S.)
Recent Developments in the Industry
- February 2026: Euroimmun Brazil announced the launch of the first serological tests on the Brazilian market. These tests are intended to aid in diagnosing Oropouche fever. The company stated that the new ANVISA-approved Anti-Oropouche Virus ELISA (IgM)/(IgG) enables determining IgG or IgM against the virus in a reliable manner. (source: euroimmunblog.com) .
Report Coverage
The arbovirus testing market report emphasizes on key regions across the globe to provide better understanding of the product to the users. Also, the report provides market insights into recent developments, trends and analyzes the technologies that are gaining traction around the globe. Furthermore, the report covers in-depth qualitative analysis pertaining to various paradigm shifts associated with the transformation of these solutions.
The report provides detailed analysis of the market while focusing on various key aspects such as competitive analysis, test type, arboviral disease, end-use, and their futuristic growth opportunities.
Arbovirus Testing Market Report Scope
| Report Attributes | Details |
| Market size value in 2025 | USD 1.31 billion |
| Market size value in 2026 | USD 1.43 billion |
| Revenue forecast in 2034 | USD 1.98 billion |
| CAGR | 4.70% from 2026 – 2034 |
| Base year | 2025 |
| Historical data | 2021 – 2024 |
| Forecast period | 2026 – 2034 |
| Quantitative units | Revenue in USD billion and CAGR from 2026 to 2034 |
| Segments covered |
|
| Regional scope |
|
| Competitive Landscape |
|
| Report Format |
|
| Customization | Report customization as per your requirements with respect to countries, region and segmentation. |
Source: Polaris Market Research Analysis
Arbovirus Testing Market FAQ's
The Arbovirus Testing Market report covering key segments are test type, arboviral disease, end-use, and region.
Arbovirus Testing Market Size Worth $1.98 Billion By 2034
Arbovirus testing market exhibiting the CAGR of 4.70% during the forecast period.
North America is leading the global market with 39.4% share.
key driving factors in Arbovirus Testing Market are Increasing occurrence and resurgence of arthropod-borne viral infections
Download Sample Report of Arbovirus Testing Market
Please fill out the form to request a customized copy of the research report.
